Cargando…
761. Age-Related Incidence of TB Infection Supporting Efficacy of BCG Vaccination
BACKGROUND: Mycobacterium tuberculosis (MTB) is a major, and potentially preventable, cause of morbidity and mortality worldwide. Bacillus Calmette-Guerin (BCG) remains the only licensed vaccine for TB, and while efficacy has been demonstrated in some populations, many uncertainties remain. Three BC...
Autores principales: | Sweeney, Eileen, Dahly, Darren, Seddiq, Nahed, Horgan, Mary, Corcoran, Dan, Sadlier, Corinna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255141/ http://dx.doi.org/10.1093/ofid/ofy210.768 |
Ejemplares similares
-
Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland
por: Sweeney, Eileen, et al.
Publicado: (2019) -
Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations
por: Pooransingh, Shalini, et al.
Publicado: (2020) -
Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
por: Aceves-Sánchez, Michel de Jesús, et al.
Publicado: (2021) -
Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming
por: Gonçalves, Eduardo DC, et al.
Publicado: (2007) -
Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy
por: Minassian, Angela M., et al.
Publicado: (2011)